Physician profile
Richard E Marki
NPI 1184765869
$2,894.51
in general payments reported to CMS, 2019-2025
36 companies · $201 in 2025
The $201 reported for 2025 was more than what a typical Gynecology provider received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $637 · 2020: $177 · 2021: $440 · 2022: $360 · 2023: $500 · 2024: $579 · 2025: $201.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,253 · Education: $26.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,253.32 |
| Education | $26.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $856.03 | 2019-2025 | |
| Allergan, INC. | $307.72 | 2020-2022 | |
| Lilly USA, LLC | $289.92 | 2019-2024 | Mounjaro, Trulicity, Zepbound |
| Astellas Pharma US INC | $184.37 | 2019-2025 | Veozah, Myrbetriq |
| Novo Nordisk INC | $160.67 | 2019-2020 | |
| Medtronic, INC. | $131.85 | 2021 | |
| Lupin INC. | $118.62 | 2019-2021 | |
| Hologic Sales and Service, LLC | $99.64 | 2019-2024 | Myosure Tissue Removal Device |
| Corcept Therapeutics | $69.25 | 2025 | Korlym |
| Amgen INC. | $60.38 | 2019-2024 | Prolia, Evenity |
| Millicent US INC | $55.60 | 2019-2024 | |
| Insulet Corporation | $55.05 | 2019 | |
| Merck Sharp & Dohme LLC | $45.66 | 2021-2025 | Capvaxive, Gardasil 9 |
| Meditrina | $42.37 | 2023-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $39.41 | 2025 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $30.87 | 2022-2023 | Freestyle Libre 3 |
| Indivior INC. | $29.92 | 2023 | Sublocade |
| Scynexis, INC. | $29.51 | 2022 | |
| Avion Pharmaceuticals | $26.96 | 2021-2022 | |
| Exact Sciences Corporation | $24.57 | 2023 | Cologuard Collection Kit |
| Covidien Lp | $20.74 | 2019 | |
| Currax Pharmaceuticals LLC | $16.12 | 2023 | Contrave |
| Glaxosmithkline, LLC. | $16.11 | 2023 | Trelegy Ellipta |
| Averitas Pharma INC. | $15.19 | 2025 | Qutenza |
| Vertical Pharmaceuticals, LLC | $14.96 | 2019 | |
| Exeltis, USA INC. | $14.88 | 2021 | |
| Aspira Women'S Health INC | $14.76 | 2022 | |
| Lifescan, INC. | $14.43 | 2019 | |
| Becton, Dickinson and Company | $14.42 | 2022 | |
| Therapeuticsmd, INC. | $14.38 | 2022 | |
| Esperion Therapeutics, INC. | $14.18 | 2024 | Nexletol |
| Idorsia Pharmaceuticals US INC | $13.92 | 2023 | Quviviq |
| Scilex Pharmaceuticals INC. | $13.56 | 2019 | |
| Hikma Pharmaceuticals USA | $12.90 | 2019 | |
| Mannkind Corporation | $12.90 | 2019 | |
| Amag Pharmaceuticals, INC. | $12.69 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Marki listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.